“Shift Towards Over-the-Counter (OTC) Availability and Personalized Pain Management”
- One prominent trend in the oral nonsteroidal anti-inflammatory drugs market is the growing shift towards over-the-counter (OTC) availability, driven by consumer demand for easier access to pain management solutions without the need for prescriptions
- This trend is enhancing patient autonomy, providing a convenient and cost-effective option for managing common conditions such as arthritis, muscle pain, and headaches
- For instance, OTC formulations of NSAIDs such as ibuprofen and naproxen are gaining popularity, offering fast-acting relief with lower risk of dependency compared to opioids
- These trends are transforming pain management, empowering patients to take control of their health while driving the demand for more personalized and accessible oral NSAID options
Frequently Asked Questions
The market is segmented based on Global Oral Nonsteroidal Anti-Inflammatory Drugs Market Segmentation, By Disease Indication, Arthritis, Migraine, and Ophthalmic Diseases), Drugs (Over-the-counter Drugs and Prescription), End-Users (Hospitals, Homecare, Speciality Centres, and Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) - Industry Trends and Forecast to 2032
.
The Global Oral Nonsteroidal Anti Inflammatory Drugs Market size was valued at USD 23.19 USD Billion in 2024.
The Global Oral Nonsteroidal Anti Inflammatory Drugs Market is projected to grow at a CAGR of 5.86% during the forecast period of 2025 to 2032.
The major players operating in the market include Bayer AG , Pfizer Inc , Reckitt Benckiser Group PLC , Novartis AG ,DAIICHI SANKYO COMPANY, LIMITED , Zydus Group , Lupin , GSK Plc , Glenmark Pharmaceuticals Inc , Amneal Pharmaceuticals , AstraZeneca .
The market report covers data from the North America.
